Skip to main content

Table 3 A descriptive summary of the risk factors for cardiometabolic disease, split by year group and sex. Data are mean ± SD and (range)

From: Physical fitness, physical activity and adiposity: associations with risk factors for cardiometabolic disease and cognitive function across adolescence

Variable

Year 7

Year 10

Boys

Girls

Boys

Girls

Systolic Blood Pressure (mmHg)

115 ± 12 (95 – 146)

115 ± 11 (96 – 139)

128 ± 13 (107 – 153)

124 ± 8 (105 – 146)

Diastolic Blood Pressure (mmHg)

69 ± 7 (59 – 84)

70 ± 7 (58 – 86)

73 ± 8 (56 – 85)

77 ± 6 (63 – 87)

Mean Arterial Pressure (mmHg)

84 ± 7 (72 – 99)

84 ± 7 (71 – 100)

91 ± 9 (72 – 107)

92 ± 6 (80 – 101)

Blood Glucose Concentration (mmol∙L−1)

4.02 ± 0.45 (3.10 – 5.0)

4.12 ± 0.59 (3.30 – 5.80)

4.43 ± 0.75 (3.0 – 5.50)

4.52 ± 0.53 (3.60 – 5.50)

Plasma Insulin Concentration (pmol∙L−1)

54.5 ± 32.3 (14.7 – 123.0)

67.7 ± 29.9 (22.8 – 123.0)

51.2 ± 25.8 (13.3 – 96.7)

60.2 ± 25.8 13.3 – 113.0)

HOMA-IR (AU)

1.58 ± 0.91 (0.39 – 3.40)

2.09 ± 1.02 (0.55 – 4.38)

1.65 ± 0.99 (0.39 – 3.53)

2.00 ± 0.85 (0.35 – 3.82)

IL-6 Concentration (pg∙ml−1)

1.70 ± 1.06 (0.53 – 4.68)

2.59 ± 1.33 (0.36 – 5.34)

1.38 ± 0.73 (0.59 – 3.39)

1.17 ± 0.55 (0.44 – 2.33)

IL-10 Concentration (pg∙ml−1)

2.97 ± 0.90 (0.69–5.79)

3.88 ± 1.70 (0.97 – 8.27)

2.81 ± 0.59 (1.70 – 3.82)

2.65 ± 1.08 (1.25 – 6.09)

IL-15 Concentration (pg∙ml−1)

2.45 ± 0.63 (1.28 – 3.85)

3.44 ± 1.11 (1.39 – 5.87)

2.94 ± 0.85 (1.78 – 5.4)

3.17 ± 1.17 (1.26 – 5.90)

IL-1β Concentration (pg∙ml−1)

41.0 ± 25.5 (3.55 – 106.00)

38.4 ± 20.2 (7.37 – 74.80)

43.5 ± 23.6 (6.97 – 80.60)

30.2 ± 16.9 (5.65– 76.60)

  1. HOMA-IR, Homeostatic Model Assessment of Insulin Resistance IL, Interleukin